Antagonist and agonist activities of the mouse Agouti protein fragment (91-131) at the melanocortin-1 receptor

被引:16
作者
Eberle, AN [1 ]
Bódi, J
Orosz, G
Süli-Vargha, H
Jäggin, V
Zumsteg, U
机构
[1] Univ Basel Hosp, Dept Res, Lab Endocrinol, CH-4031 Basel, Switzerland
[2] Univ Basel, Childrens Hosp, CH-4031 Basel, Switzerland
[3] Hungarian Acad Sci, Res Grp Peptide Chem, H-1518 Budapest, Hungary
来源
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH | 2001年 / 21卷 / 01期
关键词
D O I
10.1081/RRS-100107140
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antagonist and agonist activities of chemically synthetized mouse agouti protein fragment (91-131) (AP(91-131)) at the melanocortin type-1 receptor (MC1-R) were assessed using B16-F1 mouse melanoma cells in vitro and the following assay systems: (i) receptor binding, (ii) adenylate cyclase, (iii) tyrosinase, (iv) melanin production, and (v) cell proliferation. In competition binding studies AP91-131 was about 3-fold less potent than the natural agonist alpha -melanocyte-stimulating hormone (alpha -MSH) in displacing the radioligand [I-125]-[Nle(4), D-Phe(7)]-alpha -MSH (K-i 6.5 +/-0.8 nmol/l). alpha -MSH-induced tyrosinase activation and melanin production were completely inhibited by a 100-fold higher concentration of AP(91-131); the IC50 values for AP(91-131) in the two assay systems were 91 +/- 22 nM and 95 +/- 15 nM respectively. Basal melanin production and adenylate cyclase activity in the absence of agonist were decreased by AP(91-131) with IC50 values of 9.6 +/-1.8 nM and 5.0 +/-2.4 nM, respectively. This indicates inverse agonist activity of AP(91-131) Similar to that of native AR The presence of 10 nM melanin-concentrating hormone (MCH) slightly potentiated the inhibitory activity of AP91-131 in the adenylate cyclase and melanin assays. On the other hand, AP91-131 inhibited cell growth similar to alpha -MSH (IC50 11.0 +/-2.1 nM; maximal inhibition 1.8-fold higher than that of alpha -MSH). Furthermore, MC1-R was down-regulated by AP91-131 with about the same potency and time-course as with alpha -MSH. These results demonstrate that AP(91-131) displays both agonist and antagonist activities at the MC1-R and hence that it is the cysteine-rich region of agouti protein which inhibits and mimics the different alpha -MSH functions, most likely by simultaneous modulation of different intracellular signalling pathways.
引用
收藏
页码:25 / 45
页数:21
相关论文
共 58 条
  • [1] Agouti related protein in the rat adrenal cortex: Implications for novel autocrine mechanisms modulating the actions of pro-opiomelanocortin peptides
    Bicknell, AB
    Lomthaisong, K
    Gladwell, RT
    Lowry, PJ
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2000, 12 (10) : 977 - 982
  • [2] BIRNBAUMER M, 1992, J BIOL CHEM, V267, P11783
  • [3] AGOUTI ANTAGONISM OF MELANOCORTIN BINDING AND ACTION IN THE B16F10 MURINE MELANOMA CELL-LINE
    BLANCHARD, SG
    HARRIS, CO
    ITTOOP, ORR
    NICHOLS, JS
    PARKS, DJ
    TRUESDALE, AT
    WILKISON, WO
    [J]. BIOCHEMISTRY, 1995, 34 (33) : 10406 - 10411
  • [4] BOCKAERT J, 1976, J BIOL CHEM, V251, P2653
  • [5] New strategy for the synthesis of large peptides as applied to the C-terminal cysteine-rich 41 amino acid fragment of the mouse agouti protein
    Bodi, J
    SuliVargha, H
    Ludanyi, K
    Vekey, K
    Orosz, G
    [J]. TETRAHEDRON LETTERS, 1997, 38 (18) : 3293 - 3296
  • [6] MOLECULAR CHARACTERIZATION OF THE MOUSE AGOUTI LOCUS
    BULTMAN, SJ
    MICHAUD, EJ
    WOYCHIK, RP
    [J]. CELL, 1992, 71 (07) : 1195 - 1204
  • [7] MOLECULAR-CLONING AND EXPRESSION OF THE HUMAN MELANOCYTE STIMULATING HORMONE RECEPTOR CDNA
    CHHAJLANI, V
    WIKBERG, JES
    [J]. FEBS LETTERS, 1992, 309 (03) : 417 - 420
  • [8] Cone RD, 2000, RECEPTORS, P405
  • [9] Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat
    Cowley, MA
    Pronchuk, N
    Fan, W
    Dinulescu, DM
    Colmers, WF
    Cone, RD
    [J]. NEURON, 1999, 24 (01) : 155 - 163
  • [10] MELANIN-CONCENTRATING HORMONE-BINDING TO MOUSE MELANOMA-CELLS IN-VITRO
    DROZDZ, R
    SIEGRIST, W
    BAKER, BI
    CHLUBADETAPIA, J
    EBERLE, AN
    [J]. FEBS LETTERS, 1995, 359 (2-3): : 199 - 202